Synthesis and characterization of magnetic nanocomposite for in vitro evaluation of irinotecan using human cell lines

Authors

TUBA TARHAN

DOI

10.3906/kim-2010-53

Abstract

In this study, magnetic O-carboxymethyl chitosan (MOCC) nanocomposite was synthesized and characterized as a drug delivery system for loading the anticancer drug irinotecan (CPT-11). To increase the drug loading capacity, MOCC was synthesized by linking the carboxyl group functionally to chitosan. Also, several critical factors such as concentration, the dose of MOCC, and contact time for optimum drug loading condition were investigated. The loading capacity of CPT-11 onto MOCC was calculated as 5.6 mg/g, and the loaded drug concentration was calculated as 0.04787 mM at pH value of 5. Besides, the cytotoxic properties of MOCC, CPT- 11 loaded MOCC (MOCC-CPT-11), and free CPT-11 were studied on glioblastoma multiforme cell lines, including U87 and U373. According to the results, the MOCC-CPT-11 showed at least as toxic effect as free CPT-11 even at very low concentrations, while the MOCC showed slight toxicity (cell viability of 96% to 78%) on U373 cell lines at all concentrations and for 24 h and 48 h incubation times. Moreover, the results showed that the MOCC indicated significant toxicity in increasing concentrations and incubation times, and the MOCC-CPT-11 is as toxic as free CPT-11 on U87 cells at all concentrations and incubation times.

Keywords

Drug nanocarrier, magnetic nanocomposite, cytotoxicity, glioblastoma multiforme, irinotecan

First Page

540

Last Page

550

Recommended Citation

TARHAN, TUBA (2021) "Synthesis and characterization of magnetic nanocomposite for in vitro evaluation of irinotecan using human cell lines," Turkish Journal of Chemistry: Vol. 45: No. 3, Article 4. https://doi.org/10.3906/kim-2010-53
Available at: https://journals.tubitak.gov.tr/chem/vol45/iss3/4